Our study results suggested that AZGP1 might serve as a candidate tumor suppressor and prognostic biomarker in primary gastric cancers and be a potential target for therapeutic intervention; however, the molecular mechanisms involved in the regulation of AZGP1 in gastric cancer warrants further investigation. This evidence concerns the gene AZGP1 and neoplasm.